Cargando…
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
The outstanding clinical success of immune checkpoint blockade has revived the interest in underlying mechanisms of the immune system that are capable of eliminating tumors even in advanced stages. In this scenario, CD4 and CD8 T cell responses are part of the cancer immune cycle and both population...
Autores principales: | Ostroumov, Dmitrij, Fekete-Drimusz, Nora, Saborowski, Michael, Kühnel, Florian, Woller, Norman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769828/ https://www.ncbi.nlm.nih.gov/pubmed/29032503 http://dx.doi.org/10.1007/s00018-017-2686-7 |
Ejemplares similares
-
Role of CD8(+) T lymphocyte cells: Interplay with stromal cells in tumor microenvironment
por: Xie, Qin, et al.
Publicado: (2021) -
Virus infections in tumors pave the way for tumor-directed DC-vaccines
por: Woller, Norman, et al.
Publicado: (2012) -
PD-1/CTLA-4 Blockade Leads to Expansion of CD8(+)PD-1(int) TILs and Results in Tumor Remission in Experimental Liver Cancer
por: Bufe, Sandra, et al.
Publicado: (2022) -
CD4+CD8+ Double-Positive T-Lymphocytes: Pitfalls
por: Yavaşoğlu, İrfan
Publicado: (2020) -
Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer
por: Erlangga, Zulrahman, et al.
Publicado: (2019)